Bailard, Inc. Werewolf Therapeutics, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$1.98 - $4.3 $35,891 - $77,946	18,127 New	18,127 $47,000
Q3 2022 Oct 18, 2022	SELL	$4.14 - $7.42 $4,140 - $7,420	-1,000 Reduced 4.72%	20,200 $91,000
Q2 2022 Jul 27, 2022	BUY	$3.43 - $5.98 $72,716 - $126,776	21,200 New	21,200 $87,000

31.8M

700

500

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $47M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.